SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vernalis
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nigel bates who wrote (2)6/27/2005 5:19:50 AM
From: tuck  Read Replies (1) of 20
 
Interim frovatriptan results for prevention of menstrually related migraine:

Message 21452255

We're only crossing posts
for Nigel . . .

"Nigel just needs this helping hand . . ."

Edit: Just noticed that last PR said they had enough cash for three years. How/when did they get that/What did I miss?

Edit2: Good God, this thing's basically been basing for two bloody years!

finance.yahoo.com

With that much cash and possible market expansion for Frova next year, this could be a sleeper hit? What's your take on it know?

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News